rs1126933
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_001793.6(CDH3):c.1689G>A(p.Gln563Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 30) 
 Exomes 𝑓:  6.8e-7   (  0   hom.  ) 
Consequence
 CDH3
NM_001793.6 synonymous
NM_001793.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.134  
Publications
40 publications found 
Genes affected
 CDH3  (HGNC:1762):  (cadherin 3) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. In addition, aberrant expression of this protein is observed in cervical adenocarcinomas. Mutations in this gene are associated with hypotrichosis with juvenile macular dystrophy and ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome (EEMS). [provided by RefSeq, Nov 2015] 
CDH3 Gene-Disease associations (from GenCC):
- EEM syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital hypotrichosis with juvenile macular dystrophyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7). 
BP6
Variant 16-68687630-G-A is Benign according to our data. Variant chr16-68687630-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3675101.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-0.134 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000132  AC: 2AN: 151934Hom.:  0  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
151934
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461836Hom.:  0  Cov.: 43 AF XY:  0.00  AC XY: 0AN XY: 727224 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1461836
Hom.: 
Cov.: 
43
 AF XY: 
AC XY: 
0
AN XY: 
727224
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44722
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39692
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53412
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
1111972
Other (OTH) 
 AF: 
AC: 
0
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000132  AC: 2AN: 151934Hom.:  0  Cov.: 30 AF XY:  0.0000270  AC XY: 2AN XY: 74164 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
151934
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
2
AN XY: 
74164
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
0
AN: 
41390
American (AMR) 
 AF: 
AC: 
0
AN: 
15266
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5140
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4812
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10572
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
67974
Other (OTH) 
 AF: 
AC: 
0
AN: 
2082
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000203476), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.375 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Feb 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.